Category: Pharmaceuticals
Guardant Health partners with top pharma companies to speed clinical trials
Guardant Health, an oncology-focused company based in California in the US, is partnering with leading international pharmaceutical companies to create a 500-plus-gene liquid biopsy panel that will help drug companies accelerate clinical trials and the development of targeted cancer drugs […]
Novartis invests in potential cardiovascular therapies from Ionis
Basel, Switzerland-based multinational pharmaceutical company Novartis International AG has entered into a collaboration and option agreement with Ionis Pharmaceuticals Inc. and its subsidiary Akcea Therapeutics Inc. to license two experimental cardiovascular treatments. The investigational antisense therapies – called AKCEA-APO(a)-LRx and […]
US judge favors Amgen Inc. in patent lawsuit against Sanofi, Regeneron
A federal judge in the state of Delaware in the US has favored California-based multinational biopharmaceutical company Amgen Inc. in a patent infringement lawsuit filed against Sanofi SA and Regeneron Pharmaceuticals, Inc. over a cholesterol drug. U.S. District Judge Sue […]
Quetta, Pakistan launches five-day polio campaign as officials find rare strain
The southwestern city of Quetta, capital of the Balochistan province in Pakistan, has launched a new five-day polio immunization campaign for children under five years of age after sewage samples were found to contain a rare strain of the virus, […]
Singapore creates national action plan against antimicrobial resistance
As more and more Singaporeans use antibiotics as a quick fix for their ailments, the country’s governmentaims to tackle the growing problem of antimicrobial resistance (AMR) in the country with the development a national action plan. Singapore’s Ministry of Health […]
WHO: Successful Ebola vaccine may be available for use by 2018
According to the World Health Organization (WHO), a successful Ebola vaccine that protects against the fatal virus may be available for use by 2018 as it is currently being fast-tracked for regulatory approval. Trials conducted in Guinea, one of the […]
“Landmark” drug is first to work in primary progressive multiple sclerosis
A “landmark” drug that alters the human immune system to treat multiple sclerosis (MS) has been found to be the first drug shown to work in the primary progressive form of the disease in trials. The drug, called ocrelizumab, is […]
Allergan to acquire Acelity’s LifeCell for US$2.9 bn
Global pharmaceutical company Allergan Plc has announced its plans to acquire Acelity LP Inc.’s regenerative medicine unit Life Cell in a US$2.9 billion deal that will expand Allergan’s portfolio of medical aesthetics, breast implants and tissue expanders, the company said. […]
Mylan to sell generic version of allergy drug EpiPen for US$300
Mylan, an American global generic and specialty pharmaceuticals company, announced that they will release a generic version of the life-saving allergy drug EpiPen for US$300, which is about 50% of the current price of the drug. The company recently came […]
Prescription drug spending worldwide to hit US$1.5 tn in 2021, report says
The annual growth rate of global spending on prescription medicines is expected to decrease and become more balanced in the next five years, although it is estimated to reach nearly US$1.5 trillion by the year 2021, according to a forecast […]
